Why the study?
A sudden increase in BP can damage target organs before reaching diagnostic cut-offs for hypertensive emergencies, prompting an analysis of guideline recommendations for treatment individualization based on patient susceptibility.
Do current hypertension guidelines recommend adjusting blood pressure cut-offs for impending hypertensive emergency based on patient susceptibility?
Do current hypertension guidelines recommend adjusting blood pressure cut-offs for impending hypertensive emergency based on patient susceptibility?
Current hypertension guidelines fail to incorporate patient vulnerability, such as prior organ damage and comorbidities, into blood pressure thresholds for diagnosing impending hypertensive emergencies.
May support adjusting BP thresholds for impending HTN-E by HMOD status; leaves open prospective validation in protocols.
Background Hypertensive emergencies (HTN-E) are important due to a high risk of mortality. However, a sudden increase in blood pressure (BP) can damage target organs before the BP reaches cut-offs to diagnose HTN-E. We (i) analyse HTN guidelines for recommendations of treatment individualization, such as adjusting BP cut-offs for hypertensive urgency or impending HTN-E according to patient's susceptibility to complications (because of previous hypertension-mediated organ damage [HMOD], cardiovascular events and comorbid conditions), and (ii) provide a rationale for the inclusion of patient's susceptibility in protocols for treatment of acute HTN-E. Methods We searched PubMed, SCOPUS, Science Direct, Springer, Oxford Press, Wiley, SAGE and Google Scholar for the following terms: arterial hypertension, impending, emergency, target organ damage, hypertension-mediated organ damage, and comorbidity. Results The available guidelines do not recommend that when we estimate the probability of HTN-E in a patient with very high BP, we take into account not only the 'aggressive factor' (i.e. history of HTN, absolute BP values and rate of its increase), but also the 'vulnerability of the patient' due to previous major adverse cardio-vascular events, HMOD and comorbid conditions. Conclusion The risk does not depend only on the aggressiveness of the health threat but also on the strength of the host's defence. It is, therefore, surprising that one side of the natural interaction (i.e. susceptibility of a patient) is overlooked in almost all available guidelines on HTN.
No takes yet. Share an insight, caveat, or question.
Koraćević et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: